The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Humira Market Research Report 2024

Global Humira Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1409610

No of Pages : 93

Synopsis
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The global Humira market was valued at US$ 17070 million in 2023 and is anticipated to reach US$ 9235.6 million by 2030, witnessing a CAGR of -8.3% during the forecast period 2024-2030.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
This report aims to provide a comprehensive presentation of the global market for Humira, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humira.
Report Scope
The Humira market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Humira market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humira manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Eisai
Cadila Healthcare
Amgen
Boehringer Ingelheim
Samsung Bioepis
Biocon
Fresenius Kabi
Celltrion
Coherus
Sandoz
Torrent Pharmaceuticals
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Humira manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Humira in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Humira Market Overview
1.1 Product Overview and Scope of Humira
1.2 Humira Segment by Type
1.2.1 Global Humira Market Value Comparison by Type (2024-2030)
1.2.2 Humira Syringe
1.2.3 Humira Pen
1.3 Humira Segment by Application
1.3.1 Global Humira Market Value by Application: (2024-2030)
1.3.2 Ankylosing Spondylitis
1.3.3 Rheumatoid Arthritis
1.3.4 Crohn’s Disease
1.3.5 Others
1.4 Global Humira Market Size Estimates and Forecasts
1.4.1 Global Humira Revenue 2019-2030
1.4.2 Global Humira Sales 2019-2030
1.4.3 Global Humira Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Humira Market Competition by Manufacturers
2.1 Global Humira Sales Market Share by Manufacturers (2019-2024)
2.2 Global Humira Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Humira Average Price by Manufacturers (2019-2024)
2.4 Global Humira Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Humira, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Humira, Product Type & Application
2.7 Humira Market Competitive Situation and Trends
2.7.1 Humira Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Humira Players Market Share by Revenue
2.7.3 Global Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Humira Retrospective Market Scenario by Region
3.1 Global Humira Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Humira Global Humira Sales by Region: 2019-2030
3.2.1 Global Humira Sales by Region: 2019-2024
3.2.2 Global Humira Sales by Region: 2025-2030
3.3 Global Humira Global Humira Revenue by Region: 2019-2030
3.3.1 Global Humira Revenue by Region: 2019-2024
3.3.2 Global Humira Revenue by Region: 2025-2030
3.4 North America Humira Market Facts & Figures by Country
3.4.1 North America Humira Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Humira Sales by Country (2019-2030)
3.4.3 North America Humira Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Humira Market Facts & Figures by Country
3.5.1 Europe Humira Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Humira Sales by Country (2019-2030)
3.5.3 Europe Humira Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Humira Market Facts & Figures by Country
3.6.1 Asia Pacific Humira Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Humira Sales by Country (2019-2030)
3.6.3 Asia Pacific Humira Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Humira Market Facts & Figures by Country
3.7.1 Latin America Humira Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Humira Sales by Country (2019-2030)
3.7.3 Latin America Humira Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Humira Market Facts & Figures by Country
3.8.1 Middle East and Africa Humira Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Humira Sales by Country (2019-2030)
3.8.3 Middle East and Africa Humira Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Humira Sales by Type (2019-2030)
4.1.1 Global Humira Sales by Type (2019-2024)
4.1.2 Global Humira Sales by Type (2025-2030)
4.1.3 Global Humira Sales Market Share by Type (2019-2030)
4.2 Global Humira Revenue by Type (2019-2030)
4.2.1 Global Humira Revenue by Type (2019-2024)
4.2.2 Global Humira Revenue by Type (2025-2030)
4.2.3 Global Humira Revenue Market Share by Type (2019-2030)
4.3 Global Humira Price by Type (2019-2030)
5 Segment by Application
5.1 Global Humira Sales by Application (2019-2030)
5.1.1 Global Humira Sales by Application (2019-2024)
5.1.2 Global Humira Sales by Application (2025-2030)
5.1.3 Global Humira Sales Market Share by Application (2019-2030)
5.2 Global Humira Revenue by Application (2019-2030)
5.2.1 Global Humira Revenue by Application (2019-2024)
5.2.2 Global Humira Revenue by Application (2025-2030)
5.2.3 Global Humira Revenue Market Share by Application (2019-2030)
5.3 Global Humira Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Humira Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Humira Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Humira Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Cadila Healthcare
6.3.1 Cadila Healthcare Corporation Information
6.3.2 Cadila Healthcare Description and Business Overview
6.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cadila Healthcare Humira Product Portfolio
6.3.5 Cadila Healthcare Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Humira Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen Humira Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Humira Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Samsung Bioepis
6.6.1 Samsung Bioepis Corporation Information
6.6.2 Samsung Bioepis Description and Business Overview
6.6.3 Samsung Bioepis Humira Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Samsung Bioepis Humira Product Portfolio
6.6.5 Samsung Bioepis Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Humira Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Humira Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Fresenius Kabi
6.8.1 Fresenius Kabi Corporation Information
6.8.2 Fresenius Kabi Description and Business Overview
6.8.3 Fresenius Kabi Humira Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fresenius Kabi Humira Product Portfolio
6.8.5 Fresenius Kabi Recent Developments/Updates
6.9 Celltrion
6.9.1 Celltrion Corporation Information
6.9.2 Celltrion Description and Business Overview
6.9.3 Celltrion Humira Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Celltrion Humira Product Portfolio
6.9.5 Celltrion Recent Developments/Updates
6.10 Coherus
6.10.1 Coherus Corporation Information
6.10.2 Coherus Description and Business Overview
6.10.3 Coherus Humira Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Coherus Humira Product Portfolio
6.10.5 Coherus Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Corporation Information
6.11.2 Sandoz Humira Description and Business Overview
6.11.3 Sandoz Humira Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sandoz Humira Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Torrent Pharmaceuticals
6.12.1 Torrent Pharmaceuticals Corporation Information
6.12.2 Torrent Pharmaceuticals Humira Description and Business Overview
6.12.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Torrent Pharmaceuticals Humira Product Portfolio
6.12.5 Torrent Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Humira Industry Chain Analysis
7.2 Humira Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Humira Production Mode & Process
7.4 Humira Sales and Marketing
7.4.1 Humira Sales Channels
7.4.2 Humira Distributors
7.5 Humira Customers
8 Humira Market Dynamics
8.1 Humira Industry Trends
8.2 Humira Market Drivers
8.3 Humira Market Challenges
8.4 Humira Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’